ISRIB regulates UFMylation system homeostasis in fibroblasts to attenuate ER stress–associated inflammation and cellular senescence
Frontiers in Pharmacology · 12.11.2026 · 17
DOI: 10.3389/fphar.2026.1964615 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 12.11.2026. Verfasst von Hang Zhang und 6 weiteren Autor:innen. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Intervertebral disc degeneration (IVDD) is a major contributor to chronic low back pain, but effective treatments that target the underlying disease process remain limited. In this study, we investigated the therapeutic potential of targeting the DDRGK1/UFMylation system to reduce endoplasmic reticulum (ER) stress, inflammation, and cellular senescence in fibroblasts. We demonstrated that ISRIB, a selective ER stress inhibitor, significantly suppressed thapsigargin (Tg)-induced inflammatory responses and reduced DDRGK1 expression in rat fibroblasts. Notably, overexpression of DDRGK1, a key component of the UFMylation system, alleviated ER stress and improved protein quality control, effectively reversed Tg-induced cellular senescence, restored proliferation capacity, and attenuated the expression of inflammatory markers. Importantly, in vivo experiments using a needle-puncture rat tail model of IVDD confirmed that DDRGK1 overexpression significantly ameliorated intervertebral disc degeneration. These findings indicate that ISRIB attenuates ER stress–associated inflammatory and senescent phenotypes in fibroblasts, and that DDRGK1 overexpression alleviates disc degeneration in a rat tail puncture model, suggesting the UFMylation system as a potential therapeutic target for IVDD. warranting further validation in disc-derived cells.
Zitieren
APA
Zhang, H., Chen, J., Rong, K., Ma, H., Cao, X., Zhou, T., & Zhao, J. (2026). ISRIB regulates UFMylation system homeostasis in fibroblasts to attenuate ER stress–associated inflammation and cellular senescence. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1964615
Vancouver
Zhang H, Chen J, Rong K, Ma H, Cao X, Zhou T, et al. ISRIB regulates UFMylation system homeostasis in fibroblasts to attenuate ER stress–associated inflammation and cellular senescence. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1964615
BibTeX
@article{Zhang2026,
author = {Zhang, Hang and Chen, Jianan and Rong, Kewei and Ma, Hailong and Cao, Xiankun and Zhou, Tangjun and Zhao, Jie},
title = {ISRIB regulates UFMylation system homeostasis in fibroblasts to attenuate ER stress–associated inflammation and cellular senescence},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1964615}
}
EUVIMED